10618696

Source:http://linkedlifedata.com/resource/pubmed/id/10618696

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0026769, umls-concept:C0034107, umls-concept:C0087111, umls-concept:C0205329, umls-concept:C0208973, umls-concept:C0678057, umls-concept:C0871261, umls-concept:C1335499, umls-concept:C1517892, umls-concept:C1704632, umls-concept:C1704666, umls-concept:C1706817, umls-concept:C2911692, umls-concept:C2926735
pubmed:issue	6
pubmed:dateCreated	2000-1-20
pubmed:abstractText	To determine if there are variables linked to responsiveness to pulse cyclophosphamide/methylprednisolone therapy in progressive Multiple Sclerosis (MS).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9509185
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cycloheximide, http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1352-4585
pubmed:author	pubmed-author:DawsonD MDM, pubmed-author:HaflerD ADA, pubmed-author:HoeggJ MJM, pubmed-author:KhouryS JSJ, pubmed-author:OlekM JMJ, pubmed-author:OravE JEJ, pubmed-author:StazzoneLL, pubmed-author:WeinerH LHL
pubmed:issnType	Print
pubmed:volume	5
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	403-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:10618696-Adult, pubmed-meshheading:10618696-Age of Onset, pubmed-meshheading:10618696-Cycloheximide, pubmed-meshheading:10618696-Databases, Factual, pubmed-meshheading:10618696-Disease Progression, pubmed-meshheading:10618696-Drug Therapy, Combination, pubmed-meshheading:10618696-Female, pubmed-meshheading:10618696-Follow-Up Studies, pubmed-meshheading:10618696-Glucocorticoids, pubmed-meshheading:10618696-Humans, pubmed-meshheading:10618696-Immunosuppressive Agents, pubmed-meshheading:10618696-Male, pubmed-meshheading:10618696-Methylprednisolone, pubmed-meshheading:10618696-Multiple Sclerosis, pubmed-meshheading:10618696-Recurrence, pubmed-meshheading:10618696-Retrospective Studies, pubmed-meshheading:10618696-Time Factors, pubmed-meshheading:10618696-Treatment Failure
pubmed:year	1999
pubmed:articleTitle	Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
pubmed:affiliation	Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, HIM 730, Boston, Massachusetts, MA 02115-5817, USA.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't